Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News CohBar Inc CWBR

CohBar, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapeutics targeting chronic and age-related diseases. Its processes of identifying nucleic acid sequences encoding native peptides in the mitochondrial genome, developing and optimizing novel analogs of these natural mitochondrial derived peptides (MDPs) and developing and conducting screens to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (GREY:CWBR)

No current opinion is available.

Bullboard Posts (GREY:CWBR)

Second Quarter 2021 Financial Results & Provides Update

MENLO PARK, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing...
Betteryear2 - August 10, 2021

Positive Topline Results from the Phase 1a/1b Study

CB4211 was well-tolerated and appeared safe with no serious adverse events Robust reductions in ALT and AST Reduction in...
Betteryear2 - August 10, 2021

BIO Conference going on-CWBR

MENLO PARK, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing...
decentstock - February 16, 2021

CWBR-3rd Annual Longevity Therapeutics Conference -Jan 28th

CohBar to Present at the 3rd Annual Longevity Therapeutics Conference CWBR | 7 days ago ...
decentstock - January 27, 2021

CohBar Engages LifeSci Advisors as Investor Relations

GLOBENEWSWIRE CohBar Engages LifeSci Advisors as Investor Relations Partner   09/25/2018 9:00:00 AM   ...
GreenDream - September 27, 2018

RE:RE:RE:going going gone

If only I had a crystal ball, unfortunatly I've only got an opinion. They've kept a low profile and I'd say that this up...
Oberon6 - October 18, 2017